Screening for myeloid mutations in patients with myelodysplastic syndromes and AML with myelodysplasia-related changes

Screening for myeloid mutations in patients with myelodysplastic syndromes and AML with myelodysplasia-related changes

Introduction: One of the most critical complications in myelodysplastic syndromes (MDS) is the progression to acute myeloid leukemia (AML). The dynamics of clonal evolution in MDS and how acquired mutations can be used as biomarkers to track disease progression remains under investigation. Objective...

Full description

Bibliographic Details
Main Authors: Matheus F. Bezerra, Bruna R. Larrazábal, Aleide S. Lima, Mariana R. Mello, Raphael F. Pimentel, Isabel Weinhäuser, Fernando F. Costa, Kleber Y. Fertrin, Aderson S. Araújo, Cíntia G. Machado, Marcos A. Bezerra, Antonio R. Lucena-Araujo
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
AML progression
Clonal evolution
Myelodysplastic syndrome
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137920313158

Internet

http://www.sciencedirect.com/science/article/pii/S2531137920313158

Similar Items